# Cyclosporine In Takotsubo Syndrome

Study · id `cardio:ct-nct05946772` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05946772](<https://clinicaltrials.gov/study/NCT05946772>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05946772

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 204 participants.

## Technical summary

Registry record NCT05946772. Randomized; quadruple masking; primary purpose treatment. Start 2025-02-01 (actual); primary completion 2027-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 204 participants (planned count; ClinicalTrials.gov record NCT05946772, source copy `cardio:ctgov-nct05946772-2026-05-01`, retrieved 2026-10-31)
- Started: 2025-02-01 (actual) (ClinicalTrials.gov record NCT05946772, source copy `cardio:ctgov-nct05946772-2026-05-01`, retrieved 2026-10-31)
- Primary completion: 2027-02 (anticipated) (ClinicalTrials.gov record NCT05946772, source copy `cardio:ctgov-nct05946772-2026-05-01`, retrieved 2026-10-31)
- Completion: 2028-02 (anticipated) (ClinicalTrials.gov record NCT05946772, source copy `cardio:ctgov-nct05946772-2026-05-01`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT05946772, source copy `cardio:ctgov-nct05946772-2026-05-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05946772-2026-05-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: Cyclosporine In Takotsubo Syndrome
- Acronym: CIT
- Condition: Takotsubo Cardiomyopathy
- Intervention (Drug): Cyclosporine A
- Intervention (Drug): Placebo
- Lead sponsor: University Hospital Heidelberg
- Lead sponsor class: OTHER
- Collaborator: German Centre of Cardiovascular Research (DZHK)
- Collaborator class: UNKNOWN
- Collaborator: Coordinating Centre for Clinical Studies (KKS) Heidelberg
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry lists this organization as the lead sponsor: University Hospital Heidelberg (`cardio:org-university-hospital-heidelberg`)

## Provenance

Content hash: 3598454fb305ed53571c4e5fedaebf2343bb4d2fa56a65be27fba3a58482e1cc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
